Cite
Supplementary table 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
MLA
David N. Church, et al. Supplementary Table 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22459196.v1.
APA
David N. Church, Tjalling Bosse, Hans W. Nijman, Vincent T.H.B.M. Smit, Ian P.M. Tomlinson, Carien L. Creutzberg, Paul Klenerman, Elisabeth M. Osse, Cor D. de Kroon, Remi A. Nout, Claire Palles, Marco de Bruyn, Emanuele Marchi, Ellen Stelloo, Luke Freeman-Mills, Florine A. Eggink, & Inge C. van Gool. (2023). Supplementary table 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. https://doi.org/10.1158/1078-0432.22459196.v1
Chicago
David N. Church, Tjalling Bosse, Hans W. Nijman, Vincent T.H.B.M. Smit, Ian P.M. Tomlinson, Carien L. Creutzberg, Paul Klenerman, et al. 2023. “Supplementary Table 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer,” March. doi:10.1158/1078-0432.22459196.v1.